Test Sensitivity
Solutions' RB1 tests were developed from the retinoblastoma research
program funded by the Canadian Genetic Diseases Network (CGDN), a National
Centre of Excellence.
Our sensitivity is calculated only for individuals known to have a family
history, or for whom a viable tumor sample is available. Nonetheless, when
no viable tumor sample is available for unilaterally affected individuals,
our lab also analyzes blood samples only for RB1 mutations. Contact
us for more details.
Our lab's test sensitivity, based on over 1000 families analyzed to date:
